# Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy

> **NCT00759642** · PHASE2 · TERMINATED · sponsor: **University of Kansas Medical Center** · enrollment: 33 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** lapatinib

## Key facts

- **NCT ID:** NCT00759642
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2015-11
- **Final completion:** 2018-08-20
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** IRB decision
- **Last updated:** 2019-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759642, "Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00759642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*